Dr. Lee will oversee the clinical development of Lycia’s lead programs, LCA-0061 for IgE-mediated diseases and LCA-0321 for ...
Eli Lilly has bolstered its position the fast-emerging area of protein degrader drugs, agreeing a $1.6 billion-plus deal with Lycia Therapeutics spanning up to five drug targets. The pharma ...
Watch on LiveTube Now 👉 Video: Alabama Barker & Bestie Lycia Lamini Pop Out In The Drop-Top Corvette In Calabasas, CA #AlabamaBarker & Bestie #LyciaLamini Pop Out In The Drop-Top Corvette In ...